9.57
Syndax Pharmaceuticals Inc Aktie (SNDX) Neueste Nachrichten
Syndax to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 4, 2025 - GlobeNewswire
Syndax Pharmaceuticals: A Dual-Driven Catalyst for Long-Term Shareholder Value in 2025 - AInvest
Syndax to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 4, 2025 | SNDX Stock News - GuruFocus
Syndax to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 4, 2025 - GlobeNewswire Inc.
What is the dividend policy of Syndax Pharmaceuticals Inc. stockChart Pattern Opportunities With High Returns - jammulinksnews.com
How does Syndax Pharmaceuticals Inc. generate profit in a changing economyMaximize your portfolio’s growth with expert tips - jammulinksnews.com
What are the latest earnings results for Syndax Pharmaceuticals Inc.Invest smarter with daily stock recommendations - jammulinksnews.com
Is Syndax Pharmaceuticals Inc. a growth stock or a value stockAmplify your gains with low-risk picks - jammulinksnews.com
How volatile is Syndax Pharmaceuticals Inc. stock compared to the marketStay ahead with daily expert stock picks - jammulinksnews.com
How strong is Syndax Pharmaceuticals Inc. company’s balance sheetRecord-breaking gains - jammulinksnews.com
How high can Syndax Pharmaceuticals Inc. stock price go in 2025Free Best Performing Stock Alerts - metal.it
Is Syndax Pharmaceuticals Inc. a good long term investmentRecord-setting profit potential - PrintWeekIndia
What analysts say about Syndax Pharmaceuticals Inc. stockRapid market gains - PrintWeekIndia
Should I buy Syndax Pharmaceuticals Inc. stock before earningsGame-changing capital returns - jammulinksnews.com
What drives Syndax Pharmaceuticals Inc. stock priceDynamic capital growth - PrintWeekIndia
Syndax Pharmaceuticals’ Promising AML Study: A Closer Look at SNDX-5613 - TipRanks
Syndax Pharmaceuticals Inc. Stock Analysis and ForecastDouble-digit growth - Autocar Professional
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CFO Keith A. Goldan Sells 1,296 Shares - MarketBeat
Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Acquires New Shares in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Teacher Retirement System of Texas - Defense World
Analysts Set Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) PT at $34.10 - MarketBeat
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CEO Michael A. Metzger Sells 7,534 Shares - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Cut to $35.00 by Analysts at UBS Group - MarketBeat
Top Executives at Syndax Pharmaceuticals Make Significant Stock Moves! - TipRanks
Syndax Pharmaceuticals Executives Sell Shares for Tax Obligations - TradingView
Is Syndax Pharmaceuticals Inc. stock a good hedge against inflationFree Insider Trading Tips - Newser
Will Syndax Pharmaceuticals Inc. stock benefit from interest rate changesBreakout Confirmation Tool - Newser
(SNDX) Trading Advice - news.stocktradersdaily.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):